<DOC>
	<DOCNO>NCT02758379</DOCNO>
	<brief_summary>The objective clinical trial study early safety feasibility Shockwave Coronary Lithoplasty System . To demonstrate Shockwave device safely effectively deliver localized shockwave energy balloon dilatation calcify , stenotic , de novo coronary lesion .</brief_summary>
	<brief_title>Shockwave Coronary Lithoplasty Study</brief_title>
	<detailed_description>Prospective , non-randomized , single center First In Human ( FIH ) trial treatment stenotic calcify coronary lesion Shockwave Lithoplasty System . Patients enrol consent study base history instance angiogram obtain prior study . The study design demonstrate Shockwave device safely effectively deliver localized shockwave energy balloon dilatation calcify , stenotic , coronary artery . Subjects prepared PCI per institution 's standard protocol . Medications administer per treatment protocol . Femoral access obtain use 6F access sheath , guide catheter place ostia right leave coronary artery . Baseline angiography culprit lesion perform prior placement 0.014 '' guide wire . Baseline either IVUS OCT perform determine Maximum Lumen Area ( MLA ) , percent stenosis , volumetric lesion assessment . Baseline angiography perform determine lesion length , % stenosis reference vessel diameter . The investigational device prepped per IFU position target lesion . The distal end balloon catheter connect patient cable . The balloon catheter inflate 4 atm investigator deliver 10 pulse 20 second . The balloon inflate reference vessel diameter deflate reestablish flow complete one treatment cycle . The treatment cycle repeat . Angiography either IVUS OCT repeat treat lesion.. A coronary stent deploy site treatment . Angiography either IVUS OCT perform follow stent placement . Patients follow discharge 30 180 day . A subset five ( 5 ) subject receive angiographic assessment 180 day follow visit , per Sponsor 's discretion .</detailed_description>
	<mesh_term>Coronary Stenosis</mesh_term>
	<criteria>1 . At least 18 year age able give inform consent . 2 . Patients Sinus Rhythm . 3 . Patients significant ( &gt; 50 % diameter stenosis ) native coronary artery disease include stable unstable angina silent ischemia , suitable PCI . 4 . Ability tolerate dual antiplatelet agent ( i.e . aspirin , clopidogrel prasugrel ) . For 1 year single therapy life . 5 . Patient able willing comply assessment study . 6 . Stenosis LAD , RCA LCX artery ≥50 % reference vessel 2.5mm3.5 mm diameter ≤ 22 mm length , assess two orthogonal angiographic view . 7 . Calcification parallel calcium least 50 % length lesion . 8 . At time procedure subject Sinus Rhythm . 9 . Single lesion per vessel . 10 . Ability pass 0.014 '' guide wire across lesion . 1 . Concomitant use Rotablator , Cutting Balloon , investigational coronary device . 2 . Additional plan coronary intervention nontarget lesion within 180 day study procedure . 3 . Left ventricular ejection fraction &lt; 40 % 4 . Patients refuse candidate emergency coronary artery bypass grafting ( CABG ) surgery 5 . Uncontrolled severe hypertension ( systolic BP &gt; 180 mm Hg diastolic BP &gt; 110 mm Hg ) 6 . Patients candidate dual antiplatelet therapy 30 day chronic single antiplatelet therapy 7 . Severe renal failure creatinine &gt; 2.5 mg/dL 8 . Untreated preprocedural hemoglobin &lt; 10 g/dL 9 . Coagulopathy manifest platelet count &lt; 100,000 International Normalized ratio ( INR ) &gt; 1.7 ( INR require patient take warfarin within 2 week enrollment ) 10 . Patients cardiogenic shock 11 . Acute myocardial infarction ( MI ) within past one ( 1 ) month , and/or elevate CPK ( abnormal TroponinI ) time enrollment 12 . Patients life expectancy le 1 year 13 . Target main branch vessel &lt; 2.5 mm diameter 14 . Target main branch lesion &gt; 22 mm length 15 . Chronic Total Occlusion ( CTO ) . 16 . Previous stent procedure within 10 mm target lesion 17 . Prior PCI procedure within last 6 month . 18 . Target lesion demonstrate severe dissection prior plan use Shockwave device 19 . Unprotected Left Main diameter stenosis ≥ 50 % 20 . Visible thrombus ( angiography ) target lesion site 21 . Patient active systemic infection 22 . Patient externallyconnected intracardiac catheter pacemaker . 23 . Patient implantable pacemaker defibrillator . 24 . Patient connective tissue disease ( e.g. , Marfan 's syndrome ) 25 . Patient hypercoagulable disorder . 26 . Patient allergy image contrast medium premedicated . 27 . Evidence aneurysm acute thrombus target vessel . 28 . Patients prior sternotomy result thoracic surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>coronary artery disease</keyword>
	<keyword>calcify lesion</keyword>
	<keyword>lithotripsy</keyword>
</DOC>